Karpuz, Merveİlhan, MirayGültekin, Hazal EzgiÖzgenç, EmreŞenyiğit, ZeynepAtlıhan Gündoğdu, Evren2023-07-262023-07-26202297803239186579780323919531https://doi.org/10.1016/B978-0-323-91865-7.00017-1https://hdl.handle.net/20.500.12684/12509Cancer is one of the most important burdens for the health systems worldwide due to cancer-related deaths associated with late diagnosis and treatment toxicities. Diagnosis of cancer plays a critical role in reducing cancer death rates as it facilitates early prognosis and treatment. Current cancer treatment mainly includes the resection of tumor tissue, radiation treatment, and pharmaceutical treatment. Although various techniques, methods, and drugs are clinically used in cancer diagnosis and treatment, they are inadequate for early diagnosis and effective treatment. Therefore, several studies regarding cancer-targeted nanosized drug delivery systems and theranostic approach are performed. Nanovesicular systems, one of the most important types of drug delivery systems, are formulated for the effective delivery and controlled release of active compounds such as drugs, genes, phytocompounds, and imaging agents. In this chapter, different types of nanovesicles are reviewed after providing information about conventional cancer imaging and treatment. Furthermore, targeting mechanisms of nanovesicles for cancer are explained. Finally, some studies performed to develop the nanovesicles as the imaging, treatment, or theranostic system for cancer are summarized. © 2022 Elsevier Inc. All rights reserved.en10.1016/B978-0-323-91865-7.00017-1info:eu-repo/semantics/closedAccessethosomesexosomesLiposomesnanovesiclesniosomespolymersomestheranostictransfersomestumor targetingBook Chapter2192442-s2.0-85142772080